Skip to main content
Terug
HQH logo

Abrdn Healthcare Investors

Datakwaliteit: 100%
HQH
NYSE Financial Services Asset Management
€ 17,75
▲ € 0,06 (0,34%)
Marktkapitalisatie: 956,05M
Dagbereik
€ 17,70 € 18,06
52-Weeksbereik
€ 13,77 € 20,46
Volume
134.083
50D / 200D Gem.
€ 19,06 / € 17,81
Vorige Slotkoers
€ 17,69

Koershistorie

Financiële Trends

Sectorvergelijking

vs Financial Services sector mediaan (854 peers)

Metriek Aandeel Sector Mediaan
P/E 9,7 10,3
P/B 0,9 1,1
ROE % 9,2 11,7
Net Margin % 98,8 16,8
Rev Growth 5Y % 98,1 11,7
D/E 0,0 0,5

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Belangrijkste Punten

Revenue grew 98,11% annually over 5 years — strong growth
Earnings declined -46,68% over the past year
Net margin of 98,80% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of 0,0
P/E of 9,69 — trading at a low valuation

Groei

Revenue Growth (5Y)
98,11%
Revenue (1Y)826,84%
Earnings (1Y)-46,68%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
9,16%
ROIC6,76%
Net Margin98,80%
Op. Margin98,80%

Veiligheid

Debt / Equity
0,00
Current Ratio2,15
Interest Coverage0,00

Waardering

P/E Ratio
9,69
P/B Ratio0,87
EV/EBITDA9,69
Dividend Yield0,12%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 826,84% Revenue Growth (3Y) 211,42%
Earnings Growth (1Y) -46,68% Earnings Growth (3Y) 32,31%
Revenue Growth (5Y) 98,11% Earnings Growth (5Y) -10,72%
Profitability
Revenue (TTM) 99,81M Net Income (TTM) 98,61M
ROE 9,16% ROA 8,99%
Gross Margin 100,00% Operating Margin 98,80%
Net Margin 98,80% Free Cash Flow (TTM) 0,0
ROIC 6,76% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 2,15
Interest Coverage 0,00 Dividend Yield 0,12%
Valuation
P/E Ratio 9,69 P/B Ratio 0,87
P/S Ratio 9,58 PEG Ratio -0,21
EV/EBITDA 9,69 Dividend Yield 0,12%
Market Cap 956,05M Enterprise Value 956,05M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 99,81M 10,77M 10,29M 8,27M 6,48M
Net Income 98,61M 184,95M 56,33M -194,23M 155,18M
EPS (Diluted) 1,84 3,55 1,14 -4,10 3,49
Gross Profit 99,81M 10,77M 10,29M 8,27M 6,48M
Operating Income 98,61M -220.271,0 -1,19M -3,67M -6,23M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,10B 1,06B 932,49M 926,28M 1,17B
Total Liabilities 3,43M 1,40M 1,15M 9,71M 15,63M
Shareholders' Equity 1,09B 1,06B 931,34M 916,56M 1,16B
Total Debt 0,0 0,0 0,0 8,50M 11,33M
Cash & Equivalents 59,0 56,0 214,0 792,0 935,0
Current Assets 2,61M 603.882,0 39,64M 42,71M 12,40M
Current Liabilities 1,21M 1,40M 1,15M 9,71M 15,63M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#797 of 820
9
Value Defensive Investing (Benjamin Graham)
#569 of 708
11

Recente Activiteit

Ingestapt Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt Defensive Investing (Benjamin Graham)
Mar 24, 2026